Couldn't load pickup availability
A powerful, clinically backed hair regrowth treatment made with 5% minoxidil in a simple, once-a-day spray.
Minoxidil works by reactivating hair follicles and boosting blood flow to the scalp—helping stimulate regrowth and slow down hair thinning over time.
With one daily application, Hair Loss Sprayʳˣ delivers targeted scalp coverage without the mess of foams or greasy serums.
Connect with a licensed medical provider today to see if this treatment is right for you.
Hair Loss Sprayʳˣ is designed for fast, targeted application with a convenient spray bottle.
• Apply 4-6 sprays directly to the affected areas of the scalp.
• Use twice daily for best results.
• Massage lightly to distribute the formula evenly.
• Allow the treatment to fully absorb before styling or lying down.
Pro tip: Apply at night before bed to allow full absorption while you sleep.
With consistent twice-daily use, Hair Loss Spray may help slow hair thinning and support new hair growth over time.
Some users notice temporary shedding during the first few weeks, which is normal and part of the hair renewal cycle. Visible improvements typically appear within 3–6 months, with continued thickening over time.
For best results, Hair Loss Spray should be used consistently and as part of a long-term hair loss treatment plan.
The most common side effects of minoxidil include mild scalp irritation, dryness, itching, or flaking.
Some users may also experience temporary shedding during the early stages of regrowth—this is normal and often part of the hair renewal cycle.
Serious side effects are rare but can include swelling, persistent irritation, or allergic reaction. If you notice any unwanted effects, stop using the product and consult your healthcare provider.
Read important safety information about Minoxidil here. A mandatory doctor consultation is required before starting treatment. During the consultation, a medical provider will assess your health and provide detailed guidance on safe use.
Hair Loss Sprayʳˣ is not FDA-approved. The FDA does not evaluate compounded medications for safety, effectiveness, or quality.
| Time Period | Dose (mg) | Frequency |
|---|---|---|
| Week 1–4 | 0.25mg | Weekly |
| Week 5-8 | 0.5mg | Weekly |
| Week 9-12 | 1.0mg | Weekly |
| Week 13-20 | 1.5mg | Weekly |
| Week 21+ | 2.0mg | Weekly |
As seen on